FDA Approval Activities for this Drug
Moban (molindone HCl) tablets and concentrate, Endo NDA 17-111/SLR-055 & 17-938/SLR-022 | Moban (molindone hydrochloride) Tablets, Endo Pharma, Labeling Revision | Moban (molindone hydrochloride) Tablets, Endo Pharmaceuticals, Labeling Revision